Project

Seeing is believing: Unraveling inflammation processes in auto-immune diabetes with non-invasive imaging.

Duration
01 January 2014 → 31 December 2019
Funding
Research Foundation - Flanders (FWO)
Research disciplines
  • Medical and health sciences
    • Endocrinology and metabolic diseases
    • Medical imaging and therapy
    • Endocrinology and metabolic diseases
    • Medical imaging and therapy
    • Other paramedical sciences
    • Biomarker discovery and evaluation
    • Drug discovery and development
    • Medicinal products
    • Pharmaceutics
    • Pharmacognosy and phytochemistry
    • Pharmacology
    • Pharmacotherapy
    • Toxicology and toxinology
    • Other pharmaceutical sciences
    • Endocrinology and metabolic diseases
    • Medical imaging and therapy
Keywords
perfluorocarbon nanoparticles 19F MRI diabetes
 
Project description

Type 1 diabetes is an auto-immune disease in which the pancreatic beta-cells become selectively destroyed. In this project we aim to develop novel 19F MRI contrast agents which would enable in vivo kwantification of the developed immune responses. We will verify the selectivity and specificity of the developed contrast agents.